v3.26.1
Discontinued Operations - Schedule of Discontinued Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:      
Gain on sale of subsidiary interests $ 0 $ (376,506) $ 0
Income (loss) from discontinued operations, net of tax 0 373,030 (315,147)
Loss from discontinued operations before income taxes attributable to noncontrolling interests 0 (155) (1,370)
Income (loss) from discontinued operations before income taxes attributable to Roivant Sciences Ltd. 0 373,185 (313,777)
Loss on extinguishment of debt $ 0 8,848 0
Discontinued Operations, Disposed of by Sale | Dermavant      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue, net   75,437 92,082
Operating expenses:      
Cost of revenues   12,116 13,961
Research and development   24,307 61,827
Selling, general and administrative   119,879 271,310
Total operating expenses   156,302 347,098
Loss from operations   (80,865) (255,016)
Gain on sale of subsidiary interests   (376,506) 0
Change in fair value of debt   (97,322) 32,105
Interest expense   30,556 34,778
Other income, net   (11,257) (7,473)
Income (loss) from discontinued operations before income taxes   373,664 (314,426)
Income tax expense   634 721
Income (loss) from discontinued operations, net of tax   373,030 (315,147)
Loss from discontinued operations before income taxes attributable to noncontrolling interests   (155) (1,367)
Income (loss) from discontinued operations before income taxes attributable to Roivant Sciences Ltd.   373,819 (313,059)
Gain (loss) on sale of business, accumulated other comprehensive income (loss)   19,900  
Loss on extinguishment of debt   8,848 0
Share-based compensation   9,666 12,163
Change in fair value of debt   (97,322) 32,105
Depreciation and amortization   6,739 11,457
Product revenue, net | Discontinued Operations, Disposed of by Sale | Dermavant      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue, net   41,599 75,057
License, milestone and other revenue | Discontinued Operations, Disposed of by Sale | Dermavant      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue, net   $ 33,838 $ 17,025